04/26/2024 7:45 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 7:19 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 7:24 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/27/2024 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2024 5:00 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
03/18/2024 3:31 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
02/28/2024 3:14 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
|
02/28/2024 3:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
02/28/2024 3:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
02/23/2024 12:25 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024 7:47 PM | Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject) Ionic Ventures, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 1:42 PM | ARMISTICE CAPITAL, LLC (Filed by) Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 1:14 PM | Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject) CVI Investments, Inc. (Filed by)
| Form SC 13G/A | |
02/12/2024 3:30 PM | Bigger Capital, LLC (Filed by) Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject)
| Form SC 13G | |
01/22/2024 7:51 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/29/2023 11:10 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/28/2023 3:30 PM | Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject) Biodexa Pharmaceuticals Plc (Subject) Biodexa Pharmaceuticals (Subject) Cavalry Fund I LP (Filed by)
| Form SC 13G | |
12/26/2023 3:51 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/26/2023 3:53 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/26/2023 3:53 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
12/21/2023 3:30 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023 3:54 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B4 | |
12/18/2023 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
12/14/2023 4:20 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1/A | |
12/06/2023 4:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1/A | |
12/06/2023 3:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023 7:57 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1/A | |
11/27/2023 7:45 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2023 3:06 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
10/03/2023 9:10 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023 3:45 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/24/2023 3:23 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/24/2023 3:21 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/24/2023 3:22 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
07/24/2023 7:07 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023 7:27 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 3:43 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 10:52 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2023 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/26/2023 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/22/2023 3:33 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad) This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate…
And a cumulative gain of 1729%.
How does it all work? Click Here To Get Your Free Copy |
06/20/2023 3:30 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
06/20/2023 7:16 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2023 7:41 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
06/15/2023 3:51 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023 7:35 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023 11:15 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form EFFECT | |
06/02/2023 5:00 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B3 | |
06/01/2023 6:27 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2023 3:24 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/25/2023 8:53 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K/A | |
05/25/2023 8:54 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B5 | |
05/25/2023 4:25 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 424B5 | |
05/25/2023 3:39 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form POS AM | |
05/25/2023 3:46 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K/A | |
05/24/2023 4:29 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/18/2023 8:00 AM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2023 3:21 PM | Biodexa Pharmaceuticals Plc (Filer) Biodexa Pharmaceuticals (Filer)
| Form POS AM | |